composite nanoparticles;
magnetic drug targeting;
controlled release;
tamoxifen;
MRI;
D O I:
10.1016/j.biomaterials.2006.07.014
中图分类号:
R318 [生物医学工程];
学科分类号:
0831 ;
摘要:
The present study deals with the synthesis and characterization of tamoxifen-loaded magnetite/poly(L-lactic acid) composite nanoparticles (TMCN), and their in vitro anti-cancer activity against MCF-7 breast cancer cells. The composite nanoparticles with an average size of similar to 200nm, were synthesized via a solvent evaporation/extraction technique in an oil/water emulsion. The superparamagnetic property (saturation magnetization value of similar to 7emu/g) of the TMCN is provided by Fe3O4 nanoparticles of similar to 6nm encapsulated in the poly(L-lactic acid) matrix. The encapsulation efficiency of the Fe3O4 and tamoxifen as a function of the concentration in the organic phase was investigated. The uptake of TMCN and tamoxifen by MCF-7 was estimated from the intracellular iron concentration. After 4h incubation of MCF-7 with TMCN, significant changes in the cell morphology were discernible from phase contrast microscopy. Cytotoxicity assay shows that while the Fe3O4-loaded poly(L-lactic acid) composite nanoparticles exhibit no significant cytotoxicity against MCF-7, similar to 80% of the these cells were killed after incubation for 4 days with TMCN. (c) 2006 Elsevier Ltd. All rights reserved.